Target intelligence / Profile preview

Fungal RNA interference pathway

Molecular classification
Enzyme (Dicer, RNA-dependent RNA polymerase, Argonaute), Other (small RNA pathways)
01

Overview

The fungal RNA interference (RNAi) pathway encompasses diverse mechanisms for small RNA (sRNA) biogenesis and function, primarily involving core components Dicer (RNase-III enzyme cleaving dsRNA into 21-25 nt siRNAs or miRNAs), Argonaute (in RISC complex for target mRNA slicing or repression), and RNA-dependent RNA polymerase (RdRP, amplifying dsRNA from aberrant RNA). In species like Neurospora crassa and Schizosaccharomyces pombe, it mediates genomic defense against transgenes or viruses (quelling), heterochromatin formation at centromeres and rDNA loci via H3K9 methylation, DNA damage checkpoints by inhibiting protein synthesis, and meiotic silencing of unpaired DNA. These pathways often start with aberrant RNA or ssDNA templates producing antisense RNA (aRNA) via dual DdRP/RdRP activity, processed into sRNAs for gene silencing. In plant-pathogenic fungi like Botrytis cinerea, exogenous dsRNA is taken up, triggering RNAi to downregulate essential genes such as those in ergosterol biosynthesis, inhibiting growth and infection. This positions fungal RNAi as a promising antifungal target, exemplified by topical dsRNA sprays reducing postharvest grey mold decay without broad toxicity.

Other names
Fungal RNAi pathwayFungal small RNA biogenesis pathwaysFungal quelling pathwayFungal heterochromatin RNAi pathway
02

Mechanism of action

RNA interference (processing dsRNA into siRNA/miRNA by Dicer, loading into Argonaute-containing RISC for mRNA cleavage or translational repression; aberrant RNA conversion to dsRNA by RdRP; aRNA production from ssDNA by DdRP activity)

03

Biological functions

Genomic defenseHeterochromatin formationGene regulationDNA damage responseMeiotic silencing
04

Disease associations

Infection (fungal pathogens)
05

Interacting drugs

dsRNA-ERG (synthetic double-stranded RNA targeting ergosterol biosynthesis via RNAi uptake)

1 more in the full profile.

Beyond the preview

Go deeper on Fungal RNA interference pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal RNA interference pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call